G Medical Innovations Stock Current Valuation
| GMVDWDelisted Stock | USD 4.01 0.00 0.00% |
Valuation analysis of G Medical Innovations helps investors to measure G Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that G Medical's price fluctuation is very steady at this time. Calculation of the real value of G Medical Innovations is based on 3 months time horizon. Increasing G Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GMVDW stock is determined by what a typical buyer is willing to pay for full or partial control of G Medical Innovations. Since G Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GMVDW Stock. However, G Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.01 | Real 3.15 | Hype 4.01 | Naive 4.52 |
The intrinsic value of G Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence G Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of G Medical Innovations helps investors to forecast how GMVDW stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of G Medical more accurately as focusing exclusively on G Medical's fundamentals will not take into account other important factors: G Medical Innovations Company Current Valuation Analysis
G Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, G Medical Innovations has a Current Valuation of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
G Medical Innovations is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 11.85 Million. G Medical adds roughly 0.0 in current valuation claiming only tiny portion of equities under Health Care industry.GMVDW Fundamentals
| Return On Equity | -8.65 | |||
| Return On Asset | -1.26 | |||
| Operating Margin | (6.38) % | |||
| Revenue | 4.42 M | |||
| EBITDA | (37.75 M) | |||
| Net Income | (25.07 M) | |||
| Cash And Equivalents | 278 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 2.09 M | |||
| Current Ratio | 0.40 X | |||
| Book Value Per Share | (0.44) X | |||
| Cash Flow From Operations | (18.48 M) | |||
| Beta | -0.97 | |||
| Total Asset | 4.83 M | |||
| Retained Earnings | (115.26 M) | |||
| Working Capital | (7.12 M) | |||
| Z Score | -60.12 | |||
| Net Asset | 4.83 M |
About G Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze G Medical Innovations's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of G Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of G Medical Innovations based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in GMVDW Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |